I. Mederacke Et Al. , "Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment," ANTIVIRAL THERAPY , vol.17, no.2, pp.305-312, 2012
Mederacke, I. Et Al. 2012. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment. ANTIVIRAL THERAPY , vol.17, no.2 , 305-312.
Mederacke, I., Yurdaydin, C., Dalekos, G. N., Bremer, B., Erhardt, A., Cakaloglu, Y., ... YALÇIN, K.(2012). Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment. ANTIVIRAL THERAPY , vol.17, no.2, 305-312.
Mederacke, Ingmar Et Al. "Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment," ANTIVIRAL THERAPY , vol.17, no.2, 305-312, 2012
Mederacke, Ingmar Et Al. "Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment." ANTIVIRAL THERAPY , vol.17, no.2, pp.305-312, 2012
Mederacke, I. Et Al. (2012) . "Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment." ANTIVIRAL THERAPY , vol.17, no.2, pp.305-312.
@article{article, author={Ingmar Mederacke Et Al. }, title={Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment}, journal={ANTIVIRAL THERAPY}, year=2012, pages={305-312} }